To perform pre-clinical pharmacokinetic services for $915,076.
Ended Awarded Last action
- Contract number
- 75N93019F00153
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $915,076
Award facts
- Opportunity
-
- NIHAI2017090 Solicitation number
- Nonclinical Services for Development of Interventional Agents for Infectious Diseases Award Notice · Posted Feb 13, 2017
- Contract value 100% obligated
- $915,076.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $1,871 | |
| Other Administrative Action | -$1,871 | |
| Other Administrative Action | $0 | |
| Original award | $915,076 |
About this award
This is a delivery order award under the Nonclinical Services for Development of Interventional Agents indefinite delivery vehicle (IDV) to Sri International, a non-profit research and development institute. The $915,076.03 award is for Sri International to perform pre-clinical pharmacokinetic services for the National Institute of Allergy and Infectious Diseases, a civilian federal agency. The contract has no set-aside designation, reflecting Sri International's status as a large, established research organization capable of delivering advanced scientific and technical services to government clients across various domains, including defense, biomedical sciences, and emerging technologies. Sri International has a robust history of federal contract and grant awards, demonstrating extensive capabilities that enable rapid development of cutting-edge solutions to address complex national challenges.
Quick answers
Who was awarded contract 75N93019F00153?
75N93019F00153 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 21, 2019.
How much is contract 75N93019F00153 worth?
The government has obligated $915,076 on 75N93019F00153.
Is contract 75N93019F00153 an order under another contract?
Yes. 75N93019F00153 is a delivery order under 75N93018D00001, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93019F00153 competed?
The extent of competition for 75N93019F00153 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award